Value & Access

Our talented teams focus on two key principles in delivering our value and access projects. Firstly, we deliver constructive strategic insight informed by our strong understanding of the ‘payer mindset’ and thorough comprehension of the clinical and health economic evidence supporting your product. Secondly, we place an emphasis on the quality of presentation and writing in our value and access materials. We believe that this combination is what leads to the most robust, compelling and effectively communicated value propositions.

Market Access

Strategically combining evidence through a multidisciplinary approach to create market access solutions

Health Technology Assessment

Strategic advice, technical understanding and high quality writing to address your HTA needs

Research

Value & Access Challenges

Alongside our work on client projects, we frequently conduct our own in-house research projects aimed at investigating and understanding challenges in the market access and value assessment space. For example, we frequently contribute to the ISPOR conference with research relating to HTA processes, health economic methods and broader market access issues for therapeutic products.

Learn More

Opinion Piece

Reflections on the Upcoming EU HTA Joint Clinical Assessment Regulation

As the implementation of the EU HTA Joint Clinical Assessment (JCA) regulation in 2025 draws nearer, our teams across Value and Access and Evidence Generation have been reflecting on the challenges and opportunities the JCA brings to our industry clients. We have delved into the practicalities of the process, covering the following topics:

Considerations on what the JCA regulation will mean for systematic literature reviews
The importance of developing high-quality ‘JCA-ready’ global value dossiers
Anticipated challenges and solutions for manufacturers due to lead advanced therapy medicinal products (ATMPs) through the JCA process
How the JCA’s guidelines for direct and indirect comparisons will shape statistical analyses supporting a JCA submission
Our observations on the familiarity of and challenges associated with the JCA submission template